Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | President and COO | July 08, 2024 | July 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date July 08, 2024 · Filed July 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.67 · Expires 2034-07-08 | Direct | 307,000 |
Reported balance
After 2024-07-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-07-08 · Grant · Acquired 307,000 · Balance 307,000 F1: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 08, 2024 Filed Jul 8, 2024 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 307,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001127602-24-020203 · form4.xml · derivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,000 Underlying: Common Stock · 307,000 shares Expires 2034-07-08 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 49,113 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007628 · form4.xml · derivative · entry 7 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,227 Underlying: Common Stock · 49,113 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 37,274 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007628 · form4.xml · derivative · entry 6 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,273 Underlying: Common Stock · 37,274 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 11,177 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007628 · form4.xml · derivative · entry 5 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,177 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 37,691 | $2.62 | $98,750.42 |
DisclosureSEC source: 0001127602-24-007628 · form4.xml · nonDerivative · entry 4 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 324,214 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 49,113 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007628 · form4.xml · nonDerivative · entry 3 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 37,274 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007628 · form4.xml · nonDerivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:32 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 11,177 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007628 · form4.xml · nonDerivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 314,320 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004470 · form4.xml · derivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,320 Underlying: Common Stock · 314,320 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 314,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004470 · form4.xml · derivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,320 Underlying: Common Stock · 314,320 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| September 14, 2023 Filed Sep 14, 2023 21:05 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 10,000 | $1.38 | $13,800.00 |
DisclosureSEC source: 0001127602-23-024201 · form4.xml · nonDerivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,341 Read SEC document |
| June 20, 2023 Filed Jun 20, 2023 20:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 2,000 | $2.33 | $4,650.00 |
DisclosureSEC source: 0001127602-23-018978 · form4.xml · nonDerivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,341 Read SEC document |
| June 20, 2023 Filed Jun 20, 2023 20:10 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 10,000 | $2.34 | $23,350.00 |
DisclosureSEC source: 0001127602-23-018978 · form4.xml · nonDerivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,341 Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 37,273 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007917 · form4.xml · derivative · entry 7 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,547 Underlying: Common Stock · 37,273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 11,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007917 · form4.xml · derivative · entry 6 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,177 Underlying: Common Stock · 11,176 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 30,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007917 · form4.xml · derivative · entry 5 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,467 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 30,255 | $2.17 | $65,653.35 |
DisclosureSEC source: 0001127602-23-007917 · form4.xml · nonDerivative · entry 4 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,341 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 37,273 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007917 · form4.xml · nonDerivative · entry 3 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 11,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007917 · form4.xml · nonDerivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 30,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007917 · form4.xml · nonDerivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:56 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 442,030 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004923 · form4.xml · derivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,030 Underlying: Common Stock · 442,030 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:56 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 147,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004923 · form4.xml · derivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,340 Underlying: Common Stock · 147,340 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 11,177 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007168 · form4.xml · derivative · entry 7 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,353 Underlying: Common Stock · 11,177 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 30,466 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007168 · form4.xml · derivative · entry 6 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,467 Underlying: Common Stock · 30,466 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 25,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007168 · form4.xml · derivative · entry 5 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 25,773 | $2.85 | $73,453.05 |
DisclosureSEC source: 0001127602-22-007168 · form4.xml · nonDerivative · entry 4 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,680 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 11,177 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007168 · form4.xml · nonDerivative · entry 3 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 30,466 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007168 · form4.xml · nonDerivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:12 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 25,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007168 · form4.xml · nonDerivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 111,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004763 · form4.xml · derivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,820 Underlying: Common Stock · 111,820 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:08 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 335,470 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004763 · form4.xml · derivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,470 Underlying: Common Stock · 335,470 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| April 14, 2021 Filed Feb 11, 2022 22:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GiftCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004633 · form5.xml · nonDerivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,520 Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 30,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008779 · form4.xml · derivative · entry 9 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,933 Underlying: Common Stock · 30,467 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F6 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 25,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008779 · form4.xml · derivative · entry 8 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,290 Underlying: Common Stock · 25,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 9,555 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008779 · form4.xml · derivative · entry 7 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,797 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008779 · form4.xml · derivative · entry 6 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,797 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 26,584 | $7.19 | $191,138.96 |
DisclosureSEC source: 0001127602-21-008779 · form4.xml · nonDerivative · entry 5 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,020 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 30,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008779 · form4.xml · nonDerivative · entry 4 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 25,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008779 · form4.xml · nonDerivative · entry 3 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 9,555 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008779 · form4.xml · nonDerivative · entry 2 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:01 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,797 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-008779 · form4.xml · nonDerivative · entry 1 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:43 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 100,600 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001127602-21-005885 · form4.xml · derivative · entry 2 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,600 Underlying: Common Stock · 100,600 shares Expires 2031-02-11 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:43 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 33,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005885 · form4.xml · derivative · entry 1 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,530 Underlying: Common Stock · 33,530 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:24 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 9,651 | $1.96 | $18,915.96 |
DisclosureSEC source: 0001127602-20-014495 · form4.xml · nonDerivative · entry 2 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,495 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:24 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 26,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014495 · form4.xml · nonDerivative · entry 1 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,146 F1 · kind: Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 25,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008971 · form4.xml · derivative · entry 9 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,580 Underlying: Common Stock · 25,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F6 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 9,555 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008971 · form4.xml · derivative · entry 8 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,555 Underlying: Common Stock · 9,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F5 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008971 · form4.xml · derivative · entry 7 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,797 Underlying: Common Stock · 2,798 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F4 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,495 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-008971 · form4.xml · derivative · entry 6 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,495 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 16,025 | $2.77 | $44,389.25 |
DisclosureSEC source: 0001127602-20-008971 · form4.xml · nonDerivative · entry 5 WADE JEFFREY L · CIK 0001225767 · EVP, Corp Adm Affairs and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,621 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.